Sunshine Heart C-Pulse: device for NYHA Class III and ambulatory Class IV heart failure

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Advanced heart failure (HF) patients often have limited treatment options beyond medical therapy and resynchronization.
• Ventricular assist devices and heart transplantation are not suitable for all patients with life-limiting symptoms.

Purpose of the Study:

• To evaluate the efficacy and safety of the Sunshine Heart C-Pulse device for advanced heart failure.
• To assess the C-Pulse device's impact on New York Heart Association (NYHA) class, exercise capacity, and symptom burden.

Main Methods:

• The C-Pulse device utilizes implantable, on-demand, extra-aortic counterpulsation.
• It is designed to reduce afterload and improve cardiac perfusion in NYHA Class III and ambulatory Class IV HF patients.
• Study outcomes include improvements in NYHA class, 6-minute walk distance, and symptom questionnaires.

Main Results:

• The C-Pulse device demonstrated reductions in NYHA class and improved 6-minute walk distances.
• It also led to decreased inotrope requirements and improved HF symptom scores.
• Advantages noted include shorter operative times, no need for cardiopulmonary bypass, and no reported strokes or thrombosis, eliminating the need for anticoagulation.

Conclusions:

• The C-Pulse device shows promise as a treatment for advanced heart failure patients ineligible for VAD or transplant.
• Potential concerns include driveline exit site infections and limitations in providing full circulatory support.
• Ongoing randomized controlled studies are crucial to determine long-term efficacy and safety compared to existing therapies.